Organization
STATinMED Research Inc, Ann Arbor
1 abstract
Abstract
A DESCRIPTIVE ANALYSIS OF REAL-WORLD TREATMENT PATTERNS OF INNOVATOR INFLIXIMAB (REMICADE) AND BIOSIMILAR INFLIXIMAB IN A TREATMENT NAÏVE TURKISH RHEUMATOLOGIC DISEASE POPULATION Org: NYU Hospital for Joint Diseases, New York, STATinMED Research Inc, Ann Arbor, Janssen Scientific Affairs, LLC, Horsham, United States, Guven Hospital, Ankara, Turkey,